WINDERMERE, Fla. (Stockpickr) -- There isn't a day that goes by on Wall Street that certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
Just take a look at some of the hot movers in the under-$10 complex from Wednesday, including Royale Energy (ROYL), which skyrocketed higher by 67%; DragonWave (DRWI), which soared by 28.3%; Institutional Financial Markets (IFMI), which trended up by 24.1%; and KiOR (KIOR), which ripped to the upside by 15%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.
One low-priced stock that's been on fire of late and today is biotechnology and drugs player Acadia Pharmaceuticals (ACAD), which I highlighted in March 19's "4 Stocks Under $10 Making Big Moves" at around $6.41 a share. I mentioned in that piece that shares of ACAD were bouncing higher right above its 50-day moving average at that time of $5.98 a share with above-average volume. That spike was quickly pushing ACAD within range of triggering a major breakout trade above the upper-end of its recent sideways chart pattern at $6.67 to $6.88 a share.Guess what happened? Shares of ACAD broke out above those resistance levels just two trading sessions later on March 21 with massive upside volume. The stock went on to tag $8.81 a share, which represented a massive gain in a very short timeframe for anyone who took that trade. Shares of ACAD pulled back to a recent low of $7.40 a share, but the stock never went lower and violated those original breakout levels at $6.67 to $6.88 a share. Well, this stock is exploding higher again today with shares up over 50% as I write this trading over $12 a share. >>5 Hated Earnings Stocks That Deserve Your Love If you've been in ACAD from my original call, then now might be a great time to lock in some of those huge profits, since the stock is getting much overbought at current levels. The current relative strength index reading for ACAD is now 86.92, which represents an extremely overbought level. Low-priced stocks are something that I tweet about on a regular basis. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames. I'm not as eager to recommend investing long-term in stocks that trade less than $10 a share because these names can be very speculative, and the odds for picking the long-term winners aren't great. But I definitely love to trade stocks that are priced below $10. I like to view them as a trading vehicle with lots of volatility and lots of upside when the trade is timed right. >>5 Stocks Insiders Love Right Now When I trade under-$10 names, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 names with a catalyst, but that's secondary to the chart and volume patterns. With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV